Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia

[1]  Ning Wang,et al.  Clinical spectrum and genetic landscape for hereditary spastic paraplegias in China , 2018, Molecular Neurodegeneration.

[2]  S. Tsuji,et al.  Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment , 2018, Journal of Human Genetics.

[3]  A. Gitler,et al.  Targeted next-generation sequencing improves diagnosis of hereditary spastic paraplegia in Chinese patients , 2018, Journal of Molecular Medicine.

[4]  M. Larsen,et al.  Compound heterozygous mutations in two different domains of ALDH18A1 do not affect the amino acid levels in a patient with hereditary spastic paraplegia , 2018, neurogenetics.

[5]  E. Bertini,et al.  Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia , 2018, Clinical Neurology and Neurosurgery.

[6]  B. Tang,et al.  Identification of novel SPG11 mutations in a cohort of Chinese families with hereditary spastic paraplegia , 2018, The International journal of neuroscience.

[7]  Zhi-ying Wu,et al.  Identification and functional characterization of two missense mutations in NDRG1 associated with Charcot‐Marie‐Tooth disease type 4D , 2017, Human mutation.

[8]  A. Brice,et al.  Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias , 2017, European Journal of Human Genetics.

[9]  E. Bertini,et al.  Expanding the clinical phenotype of CAPN1-associated mutations: A new case with congenital-onset pure spastic paraplegia , 2017, Journal of the Neurological Sciences.

[10]  A. Oliveira,et al.  Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks , 2016, The Cerebellum.

[11]  N. Brüggemann,et al.  CAPN1 mutations are associated with a syndrome of combined spasticity and ataxia , 2017, Journal of Neurology.

[12]  D. Timmann,et al.  Loss-of-function mutations in the ATP13A2/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78) , 2017, Brain : a journal of neurology.

[13]  I. Jonassen,et al.  GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies , 2017, PloS one.

[14]  Hong-Fu Li,et al.  Identification of novel senataxin mutations in Chinese patients with autosomal recessive cerebellar ataxias by targeted next-generation sequencing , 2016, BMC Neurology.

[15]  B. Tang,et al.  SPG46 and SPG56 are rare causes of hereditary spastic paraplegia in China , 2016, Journal of Neurology.

[16]  P. Bauer,et al.  High Frequency of Pathogenic Rearrangements in SPG11 and Extensive Contribution of Mutational Hotspots and Founder Alleles. , 2016 .

[17]  P. Bauer,et al.  High Frequency of Pathogenic Rearrangements in SPG11 and Extensive Contribution of Mutational Hotspots and Founder Alleles , 2016, Human mutation.

[18]  A. Singleton,et al.  Genetic and phenotypic characterization of complex hereditary spastic paraplegia , 2016, Brain : a journal of neurology.

[19]  C. Gilissen,et al.  Clinical exome sequencing for cerebellar ataxia and spastic paraplegia uncovers novel gene–disease associations and unanticipated rare disorders , 2016, European Journal of Human Genetics.

[20]  O. Suchowersky,et al.  Mutations in CAPN1 Cause Autosomal-Recessive Hereditary Spastic Paraplegia. , 2016, American journal of human genetics.

[21]  H. Houlden,et al.  Hereditary Spastic Paraplegia in Greece: Characterisation of a previously unexplored population using next generation sequencing , 2015, European Journal of Human Genetics.

[22]  A. Durr,et al.  Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. , 2015, Brain : a journal of neurology.

[23]  C. Blackstone,et al.  Loss of AP-5 results in accumulation of aberrant endolysosomes: defining a new type of lysosomal storage disease , 2015, Human molecular genetics.

[24]  G. Stevanin,et al.  Delving into the complexity of hereditary spastic paraplegias: how unexpected phenotypes and inheritance modes are revolutionizing their nosology , 2015, Human Genetics.

[25]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[26]  K. Xia,et al.  SPG35 contributes to the second common subtype of AR‐HSP in China: frequency analysis and functional characterization of FA2H gene mutations , 2015, Clinical genetics.

[27]  Hung-Chou Kuo,et al.  Clinical and genetic analysis of Taiwanese patients with hereditary spastic paraplegia type 5 , 2015, European journal of neurology.

[28]  Z. Xiong,et al.  Identify mutation in amyotrophic lateral sclerosis cases using HaloPlex target enrichment system , 2014, Neurobiology of Aging.

[29]  B. Castellotti,et al.  Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. , 2014, Brain : a journal of neurology.

[30]  T. Ideker,et al.  Exome Sequencing Links Corticospinal Motor Neuron Disease to Common Neurodegenerative Disorders , 2014, Science.

[31]  Marco Y. Hein,et al.  Interaction between AP-5 and the hereditary spastic paraplegia proteins SPG11 and SPG15 , 2013, Molecular biology of the cell.

[32]  J. Fink,et al.  Hereditary spastic paraplegia: clinico-pathologic features and emerging molecular mechanisms , 2013, Acta Neuropathologica.

[33]  Henry Houlden,et al.  Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity. , 2013, American journal of human genetics.

[34]  Alexandra Durr,et al.  Loss of function of glucocerebrosidase GBA2 is responsible for motor neuron defects in hereditary spastic paraplegia. , 2013, American journal of human genetics.

[35]  C. Mummery,et al.  SPG11 Presenting with Tremor , 2012, Tremor and other hyperkinetic movements.

[36]  J. Finsterer,et al.  Hereditary spastic paraplegias with autosomal dominant, recessive, X-linked, or maternal trait of inheritance , 2012, Journal of the Neurological Sciences.

[37]  R. Guerreiro,et al.  Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis , 2012, Human molecular genetics.

[38]  D. Krainc,et al.  Pathogenic effects of novel mutations in the P‐type ATPase ATP13A2 (PARK9) causing Kufor‐Rakeb syndrome, a form of early‐onset parkinsonism , 2011, Human mutation.

[39]  K. Lindblad-Toh,et al.  A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers , 2011, Neurobiology of Disease.

[40]  A. Stray-Pedersen,et al.  Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. , 2009, Brain : a journal of neurology.

[41]  E. Bertini,et al.  Screening of ARHSP‐TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion , 2009, Human mutation.

[42]  Huey-Ling Chen,et al.  Neonatal Cholestatic Liver Disease in an Asian Patient With a Homozygous Mutation in the Oxysterol 7α-hydroxylase Gene , 2008, Journal of pediatric gastroenterology and nutrition.

[43]  F. Pasquier,et al.  Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. , 2008, Brain : a journal of neurology.

[44]  M. Ruberg,et al.  Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum , 2007, Nature Genetics.

[45]  Jan Gründemann,et al.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase , 2006, Nature Genetics.

[46]  J. Fink,et al.  Chapter 119 – Hereditary Spastic Paraplegia , 2013 .

[47]  A. Rossi,et al.  Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum , 2004, Neurology.

[48]  C. Obie,et al.  Molecular enzymology of mammalian Delta1-pyrroline-5-carboxylate synthase. Alternative splice donor utilization generates isoforms with different sensitivity to ornithine inhibition. , 1999, The Journal of biological chemistry.

[49]  A. Harding.  CLASSIFICATION OF THE HEREDITARY ATAXIAS AND PARAPLEGIAS , 1983, The Lancet.

[50]  Pask Ea,et al.  HOMOSEXUALITY AS A CRIME. , 1965 .

[51]  D. Timmann,et al.  Loss-of-function mutations in the ATP 13 A 2 / PARK 9 gene cause complicated hereditary spastic paraplegia ( SPG 78 ) , 2017 .

[52]  R. Ravazzolo,et al.  ALDH18A1 gene mutations cause dominant spastic paraplegia SPG9: loss of function effect and plausibility of a dominant negative mechanism. , 2016, Brain : a journal of neurology.

[53]  C. Mummery,et al.  SPG 11 Presenting with Tremor , 2012 .